Diabetes in rats treated with engineered probiotic
Imagine a pill that helps people control diabetes with the body's own insulin.
Jan 28, 2015
1
103
Imagine a pill that helps people control diabetes with the body's own insulin.
Jan 28, 2015
1
103
Combining a new hydrogel material with a protein that boosts blood vessel growth could improve the success rate for transplanting insulin-producing islet cells into persons with type 1 diabetes. In an animal model, the technique ...
Jun 5, 2017
0
102
In people with type I diabetes, insulin-producing beta cells in the pancreas die and are not replaced. Without these cells, the body loses the ability to control blood glucose. Researchers at the University of California, ...
Apr 4, 2017
0
252
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered ...
May 11, 2017
0
98
In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and their colleagues at Technical University of Munich have ...
Oct 21, 2016
0
47
In type 1 diabetes, the immune system attacks the body's own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don't understand what triggers the attack or how ...
Apr 11, 2016
0
3
Loss of physical strength due to muscle deterioration is a complication for people living with Type 1 diabetes that's often overlooked. New research from McMaster University shows it shouldn't be.
Sep 20, 2016
0
1
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.
Mar 17, 2015
0
20
A new stem cell study conducted at the University of Copenhagen shows how we may increase the vital production of insulin in patients suffering from diabetes. The discovery helps to more efficiently at less cost make insulin-producing ...
Nov 6, 2017
0
45
The Harvard Stem Cell Institute (HSCI), three of Harvard's clinical affiliates, and a biopharmaceutical company have formed an unusual collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to ...
Jun 17, 2016
1
241